
Jerry's Story
Jerry is a man who is used to helping other people. He spent a large majority of his life as a firefighter in Graham, NC, a town that he now has the honor of serving as their mayor. He is a father, a husband, and a war veteran who continues to serve as a volunteer in the local fire department. Jerry knows what it means to serve people and to make a difference in his community. However, when he was diagnosed with prostate cancer approximately seven years ago, this was not some

Glenn's Story
Prior to being diagnosed with prostate cancer, Glenn worked in the field of radiation oncology, and had a background in treatments for prostate cancer. During his annual physical in the early part of 2010, his internist discovered he had a PSA of 4.2 and recommended that he see a urologist. Glenn went to see a urologist that performed a biopsy and, based on his evaluation of the pathology report after the biopsy, indicated that 2 of the cores were positive for prostate cancer

Herb's Story: Whole Gland Therapy isn’t for everyone. That is why I chose HIFU.
Herb Riemenschneider, M.D., a urologist in Columbus, OH was diagnosed with low grade prostate cancer late in 2013. As a physician, he has spent years learning and training how to provide patients with the best possible patient care. He understands better than anyone what the potential side effects and the recovery of all the treatments looks like. As an urologist and prostate cancer specialist, he is on the front line and knows exactly what is at stake with a prostate cancer

Bob's Story: Every man is at risk for prostate cancer. Even your urologist.
Robert Pugach, M.D., of Los Angeles, Calif., was diagnosed with prostate cancer late in 2016. His annual exam included a PSA blood test that was abnormal so a biopsy was done which showed an early prostate cancer. Dr. Pugach faced the same dilemma that many of his patients face: What to do about a small, moderately aggressive prostate cancer? “Some would do nothing. I am a candidate for ‘surveillance.’ Some patients have cancers that never progress to the point where they